Pfizer Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Pfizer Inc.
Quantité totale PI 3 401
Quantité totale incluant filiales 5 330 (+ 1 968 pour les filiales)
Rang # Quantité totale PI 358
Note d'activité PI 4/5.0    2 103
Rang # Activité PI 321
Activité incl filiales 3,7/5.0    2 226
Symbole boursier
ISIN US7170811035
Capitalisation 145,800M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

927 396
343 310
950 10
465
 
Dernier brevet 2025 - Lipid compounds and uses thereof
Premier brevet 1903 - Substituted tetrahydrobenzazepin...
Dernière marque 2025 - OXBRYTA
Première marque 1950 - TERRAMYCIN

Filiales

111 subsidiaries with IP (1211 patents, 757 trademarks)

124 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for...
P/S Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastroint...
P/S Pharmaceutical preparations for the treatment of Pharmaceutical preparations for the treatment of...
P/S Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ...
P/S Medical apparatus, namely, infusion and injection devices for administering drugs; Medical syringes
P/S Pharmaceutical preparations for the treatment of oncological diseases
P/S Pharmaceutical preparations for the treatment of bladder cancer
P/S Pharmaceutical preparations and substances.
P/S Providing counseling and consulting in the field of healthcare insurance benefits
P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
P/S Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central n...
P/S Providing medical information in the field of heart disease; Providing information in the field o...
Invention Glp-1 receptor agonists and uses thereof. Provided herein are 6-carboxylic acids of benzimidazol...
Invention Compositions and methods for eliciting an immune response against clostridium difficile. In one ...
Invention Rsv f protein mutants. The present disclosure relates to RSV F protein mutants, nucleic acids or...
Invention Ponsegromab for use in treating cachexia in cancer patients. The invention is directed to methods...
Invention Methods of manufacturing a bifunctional compound. This disclosure pertains to the preparation of ...
Invention Methods for treatment of inflammatory bowel disease with an anti-tl1a antibody. The present discl...
Invention Coaxial mixing device for nanoparticle preparation and manufacturing equipment including such mix...
Invention Substituted pyridine and phenyl compounds. The invention relates to compounds of Formula (I), or ...
Invention Aluminum adjuvant nanoparticles, methods of manufacture, and uses thereof. In one aspect, the pre...
Invention Method for sterilizing and filling containers for pharmaceutical product and related filling syst...
Invention Method and apparatus for improved man-machine interactions. An automated smart voice-interactive...
Invention Method and system of simulating operational integrity of a pre-filled vial. Method and system of...
Invention Method and apparatus for improved human-machine interactions. An automated smart voice-interactiv...
Invention Substituted pyridine and phenyl compounds. The invention relates to compounds of Formula (I), or...
Invention Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof. The pr...
Invention Oral compositions/formulations of 2-({4-[(2s)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxo...
Invention Pyrrolidine-based glucose-dependent insulinotropic polypeptide receptor antagonists and uses ther...
Invention Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof. Described he...
Invention Improved methods for producing glycoconjugates by reductive amination in aprotic solvent. 197Stre...
Invention Media and fermentation methods for polysaccharide production in bacterial cell culture. The prese...
Invention Nitrogen-containing heterocyclic compounds. The disclosure relates to compounds of the disclosur...
Invention Novel nitrogen-containing heterocyclic compounds. The disclosure relates to compounds of the disc...
Invention Tmprss2-erg and rb1 as predictive biomarkers for treatment with a parp inhibitor. This invention ...
Invention Methods for producing nucleic acids. in vitroin vitro reaction system.
Invention Cdk4 inhibitors for use in the treatment of mantle cell lymphoma. This invention relates to thera...
Invention Methods for identifying biomarkers of treatment response and use thereof with a cdk4 inhibitor. M...
Invention Cdk4 inhibitors and combinations with cdk2 inhibitors or further agents for use in the treatment ...
Invention Polynucleotide compositions and uses thereof. The invention relates to polypeptides and RNA molec...
Invention Formulations comprising n-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds and...
Invention Indole analogs. The invention relates to compounds of Formula (I), or pharmaceutically acceptable...
Invention Synthesis of (1h-pyrazol-5-yl)cyclopentyl carbamate compounds. This disclosure relates to the nov...
Invention Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof. In...
Invention Escherichia coli saccharides and uses thereof. E. coliE. coli lipopolysaccharides. In one embodim...
Invention Immunogenic compositions and uses thereof. The present disclosure relates to compositions compris...
Invention Improved lnp formulations and uses thereof. The invention relates to lipid nanoparticles, immunog...
Invention Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof. The...
Invention Anti-gdf15 antibodies, compositions and methods of use. The invention provides antibodies, and a...
2024 Invention Immunogenic compositions against influenza. The disclosure relates to compositions and methods f...
Invention Immunogenic compositions against influenza. The invention relates to compositions and methods fo...
2023 Invention Lipid compounds and uses thereof. Compounds are provided having the following structure: (I) or ...
Invention Systems and methods for performing biological assays using a thermally sealed valve. Provided he...
Invention Dosing regimens of sirp alpha fusion proteins for treatment of cancer. Dosing regimens and metho...
Invention Injection device with a needle detection feature. The invention relates to an injection device c...
Invention Process for producing of vaccine formulations with preservatives. The present invention relates ...
Invention Compositions and methods for eliciting an immune response protective against lyme disease. The p...
Invention Multi-layered syringe with a threaded connection part and method of manufacturing same. The inve...
Invention Cysteine prototrophy. Provided herein are cells, compositions, and related methods for improved ...
2022 Invention Enhancement of cd47 blockade therapy with anti-vegf agents. Various forms of cancer and other di...
Invention Vaccination against bacterial and betacoronavirus infections. The invention relates to vaccinati...
Invention Ether-linked antiviral compounds. The invention relates to compounds of Formula I The inventio...